Use Bayesian models to create individualized vancomycin and other antimicrobial dosing recommendations within VigiLanz.
VigiLanz, the #1 ranked antimicrobial stewardship and pharmacy surveillance solution, enables you to monitor antimicrobial therapy and improve patient outcomes by ensuring safe and appropriate antimicrobial use through real-time alerts and hospital-wide surveillance. Under the new vancomycin guidelines issued by ASHP / IDSA / PIDS / SIDP in March 2020, using Bayesian software programs is the preferred approach to monitoring AUC. Now, with VigiLanz Precision Dosing powered by DoseMeRx, you can use clinically validated models to implement accurate AUC-based decision making for your patients.
- Adhere to the revised consensus guidelines
- Reduce vancomycin-associated AKI
- Implement flexible timing of drug levels
- Standardize care with data-driven dose optimization
- Improve the proportion of patients in therapeutic range
Adult
Clinically validated vancomycin models & AUC calculations made simple
+ Standard Adult, Buelga et al. (2005)
+ Complex & Critically Ill Adult, Goti et al. (2018)
+ Intermittent Hemodialysis Adult, Goti et al. (2018)
+ Obese Adult, Adane et al. (2015)
Pediatric/Adolescent
Vancomycin dosing and monitoring support for pediatrics and neonates
+ Pediatric & Adolescent, Lamarre et al. (2000)
+ Preterm & Neonate, Frymoyer et al. (2014)
Gentamicin dosing and monitoring support for pediatrics and neonates
+ Pediatric & Adolescent, Lopez et al. (2010)
+ Preterm & Neonate, Fuchs et al. (2014)
__________________________________________
Interested in scheduling an introductory call to learn more about VigiLanz Precision Dosing? Fill out the form below.
